Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
US Department of Justice
Chinese Patent Office
Cerilliant
Accenture
Colorcon
Boehringer Ingelheim
Argus Health
UBS

Generated: January 23, 2018

DrugPatentWatch Database Preview

LUZU Drug Profile

« Back to Dashboard

When do Luzu patents expire, and when can generic versions of Luzu launch?

Luzu is a drug marketed by Medicis and is included in one NDA. There are five patents protecting this drug.

This drug has sixty-four patent family members in twenty-five countries.

The generic ingredient in LUZU is luliconazole. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the luliconazole profile page.
Summary for LUZU
International Patents:64
US Patents:5
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 34
Patent Applications: 22
Drug Prices:see details
DailyMed Link:LUZU at DailyMed
Drug patent expirations by year for LUZU
Pharmacology for LUZU
Ingredient-typeAzoles
Drug ClassAzole Antifungal
Mechanism of ActionCytochrome P450 2C19 Inhibitors

US Patents and Regulatory Information for LUZU

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medicis LUZU luliconazole CREAM;TOPICAL 204153-001 Nov 14, 2013 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for LUZU

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,085,554 Method of evaluating pharmaceutical preparation containing luliconazole and index substance ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for LUZU

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Argus Health
Cipla
Teva
US Department of Justice
Cantor Fitzgerald
Fish and Richardson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot